ClariVest Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-60,000
| Closed | -$611K | – | 743 |
|
|
2021
Q1 | $611K | Buy |
60,000
+3,400
| +6% | +$34.6K | 0.02% | 382 |
|
|
2020
Q4 | $422K | Sell |
56,600
-19,000
| -25% | -$142K | 0.01% | 410 |
|
|
2020
Q3 | $260K | Sell |
75,600
-4,600
| -6% | -$15.8K | 0.01% | 432 |
|
|
2020
Q2 | $382K | Sell |
80,200
-4,500
| -5% | -$21.4K | 0.01% | 446 |
|
|
2020
Q1 | $169K | Buy |
+84,700
| New | +$169K | 0.01% | 493 |
|
|
2019
Q3 | – | Sell |
-150,998
| Closed | -$572K | – | 668 |
|
|
2019
Q2 | $572K | Sell |
150,998
-83,900
| -36% | -$318K | 0.01% | 355 |
|
|
2019
Q1 | $1.91M | Buy |
234,898
+3,700
| +2% | +$30.1K | 0.04% | 319 |
|
|
2018
Q4 | $1.87M | Sell |
231,198
-10,800
| -4% | -$87.2K | 0.04% | 323 |
|
|
2018
Q3 | $1.85M | Sell |
241,998
-6,200
| -2% | -$47.3K | 0.03% | 334 |
|
|
2018
Q2 | $1.42M | Sell |
248,198
-46,968
| -16% | -$269K | 0.02% | 392 |
|
|
2018
Q1 | $1.41M | Buy |
295,166
+17,599
| +6% | +$84K | 0.02% | 380 |
|
|
2017
Q4 | $1.36M | Buy |
277,567
+202,867
| +272% | +$996K | 0.02% | 386 |
|
|
2017
Q3 | $392K | Buy |
+74,700
| New | +$392K | 0.01% | 405 |
|
|
2014
Q4 | – | Sell |
-15,000
| Closed | -$147K | – | 553 |
|
|
2014
Q3 | $147K | Buy |
+15,000
| New | +$147K | 0.01% | 410 |
|
|
2013
Q4 | – | Sell |
-9,900
| Closed | -$72K | – | 597 |
|
|
2013
Q3 | $72K | Buy |
+9,900
| New | +$72K | ﹤0.01% | 426 |
|